Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Edoardo Mairani"'
Autor:
Sebastiano Puccio, Giuseppe Azzarello, Valeria Maffeis, Licia Laurino, Edoardo Mairani, Federica Conte, Nicola Tessari, Diego Cazzador, Elisabetta Zanoletti, Doriano Politi, Enzo Emanuelli, Giacomo Spinato, Simonetta Ausoni
Publikováno v:
Cancers, Vol 16, Iss 10, p 1895 (2024)
Sinonasal intestinal-type adenocarcinoma (ITAC) is a very rare, closely occupational-related tumor with strong histological similarities to colorectal cancer (CRC). In the latter, tumor budding (TB) is widely recognized as a negative prognostic param
Externí odkaz:
https://doaj.org/article/79178bbd86914bb3bae87ee730ba008e
Autor:
Giancarlo Ottaviano, Eugenio De Corso, Tommaso Saccardo, Leandro Maria D’Auria, Sonny Zampollo, Giuseppe D’Agostino, Edoardo Mairani, Gabriele De Maio, Bruno Scarpa, Christian Bacci, Vittorio Favero
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 8, p 1241 (2023)
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial disease that significantly impacts patients’ quality of life. New therapeutic strategies and in particular biologic treatments are now available for these patients. It has been d
Externí odkaz:
https://doaj.org/article/3f791419b147417fb535580c540d9d8d
Autor:
Giancarlo Ottaviano, Eugenio De Corso, Elena Cantone, Andrea Ciofalo, Tommaso Saccardo, Riccardo Bernardi, Edoardo Mairani, Claudio Montuori, Giuseppe Roccuzzo, Livia Soldati, Benedetto Randon, Sonny Zampollo, Alessandra Di Chicco, Francesca Visconti, Bruno Scarpa, Piero Nicolai
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 2, p 234 (2023)
Chronic rhinosinusitis with nasal polyps (CRSwNP) in the most severe forms is associated with a poor quality of life. Dupilumab has been suggested as an add-on treatment option for severe CRSwNP. Severe CRSwNP patients treated with dupilumab in diffe
Externí odkaz:
https://doaj.org/article/e097f24ff97d416fa945fedddf5ae0e8
Autor:
Giancarlo Ottaviano, Tommaso Saccardo, Giuseppe Roccuzzo, Riccardo Bernardi, Alessandra Di Chicco, Alfonso Luca Pendolino, Bruno Scarpa, Edoardo Mairani, Piero Nicolai
Publikováno v:
Journal of Personalized Medicine, Vol 12, Iss 9, p 1526 (2022)
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) represents 25–30% of all CRS cases, and in the most severe forms it is associated with a poor quality of life and a high rate of nasal polyps’ recurrence after surgery. Dupilumab has b
Externí odkaz:
https://doaj.org/article/fee4df989d05498cbebf9ffe8c0c5a29